Table 2 Perioperative findings of low dose HES vs moderate dose HES group
Variables | Low dose HES (n = 1239) | Moderate dose HES (n = 418) | p-value |
|---|---|---|---|
CPB time, min | 142.5 ± 65.1 | 150.8 ± 65.1 | .02 |
ACC time, min | 92.4 ± 48.0 | 97.9 ± 48.4 | .05 |
Operation | .23 | ||
Valve | 789 (63.6) | 279 (66.5) | |
CABG | 88 (7.1) | 20 (4.7) | |
Valve + CABG | 43 (3.4) | 15 (3.5) | |
Aorta | 171 (13.8) | 65 (15.5) | |
Others | 148 (11.9) | 39 (9.3) | |
Crystalloid administration | |||
Saline, L | 0.9 ± 1.0 | 0.8 ± 0.2 | .76 |
Balanced, L | 3.1 ± 0.7 | 3.0 ± 0.8 | .68 |
6% HES | |||
670/0.75, L | 0.21 ± 0.2 | 0.8 ± 0.3 | < .001 |
670/0.75, ml/kg | 3.9 ± 4.2 | 14.5 ± 4.9 | < .001 |
130/0.4, L | 0.4 ± 0.1 | 0.6 ± 0.2 | < .001 |
130/0.4, ml/kg | 7.8 ± 2.4 | 11.4 ± 5.3 | < .001 |
Transfusion | |||
Red blood cell, L | 0.9 ± 1.7 | 1.1 ± 1.6 | .009 |
Fresh frozen plasma, L | 0.6 ± 1.4 | 0.6 ± 1.4 | .24 |
Cryoprecipitate, L | 0.9 ± 1.9 | 1.3 ± 2.0 | < .001 |
Platelet concentrate, L | 0.9 ± 2.5 | 1.0 ± 2.9 | .15 |